KV Asia Capital Acquires Singapore-based Derma-Rx International Aesthetics (Asia)
Source: Asian Venture Capital Journal | Author(s): Mirzaan Jamwal
Southeast Asia-focused private equity firm KV Asia Capital has reached an agreement with India-based skin care company Marico Kaya Enterprises to acquire 100 percent of Marico’s subsidiary Singapore-based Derma-Rx International Aesthetics (DIAL). DIAL sells a line of skincare products under the brand Derma-Rx for conditions such as pigmentation disorders, acne, scars and wrinkles. Financial details of the transaction, which will close pending certain conditions, were not disclosed.